Page 3 - Kiran Mazumdar Shaw

Biocon Biologics to go for IPO in 18-24 months: Kiran Mazumdar-Shaw

Biocon arm buys Viatris biosimilars biz for $3.2 billion

Mohandas Pai, Kiran Mazumdar-Shaw spar over 'unknown' yogi in NSE matter

Governance experts call for further probe into the matter

Biocon's Kiran Mazumdar-Shaw calls for incentive scheme for research

India needs to incentivize industries to invest more in academic research for creating a better ecosystem of research and innovation, Biocon chairperson Kiran Mazumdar-Shaw said on Wednesday. Speaking at a book launch event organised by the Centre for Social and Economic Progress (CSEP), Mazumdar-Shaw further said as the government has come up with incentives for production, it should also come up with incentives for research. "India needs to incentivize industries to invest more in academic research to create a better ecosystem of research and innovation," she said. Speaking at the event, former Niti Aayog Vice-Chairman Arvind Panagariya said due to economic reforms India's growth accelerated from 3 per cent (before liberalisation) to 7-8 per cent. Former deputy chairman of erstwhile Planning Commission Montek Singh Ahluwalia said the difference between 1991 and now is that in 1991, there was a global consensus on what to do. "We (India) were the only odd guys out. But today, tha

Pandora Papers: 'Kunal Kashyap has no influence over Biocon-linked trust'

According to a company statement, the Deanstone Trust, which was mentioned as part of a leak of offshore tax haven files called the 'Pandora Papers,' was set up for philanthropic endeavours

Kiran Mazumdar-Shaw says husband's offshore trust wrongly implicated

Kiran Mazumdar-Shaw on Monday said media reports on the 'Pandora Papers' leak have wrongly implicated her husband's offshore trust, and termed the organisation as "bonafide" and "legitimate". The industry veteran noted that both she and her husband are law abiding citizens. Anil Ambani, Vinod Adani, Jackie Shroff, Kiran Mazumdar-Shaw, Niira Radia, Sachin Tendulkar and Satish Sharma are among the many Indians who figure in the 'Pandora Papers' that have uncovered financial assets of leaders across the world. "Media stories reporting on Pandora Papers wrongly implicate my husband's offshore trust, which is a bonafide, legitimate trust and is managed by Independent Trustees. No Indian resident holds the key to the trust as alleged in these stories," Mazumdar-Shaw, the executive chairperson of biotechnology major Biocon, said in a tweet. Later, in a regulatory filing, she elaborated on the offshore trusts. "My husband, John Shaw is a UK national who from his foreign currency earnings

Decoded: Of 'Pandora Papers', insider trading and Biocon link

Kiran Mazumdar-Shaw, executive chairperson of Biocon denied any impropriety

'Pandora Papers' wrongly implicate husband's offshore trust: Kiran Mazumdar

Kiran Mazumdar-Shaw on Monday said the 'Pandora Papers' have wrongly implicated her husband's offshore trust, and termed the organisation as "bonafide" and "legitimate"

India to take 9 more months for full vaccination; avoid congregations: Shaw

India has done a tremendous job on the vaccination drive but it will take at least nine more months to fully vaccinate all adults, Biocon Chairperson Kiran Mazumdar Shaw said on Tuesday.

Biocon controversy: Sebi's insider trading laws may need an overhaul

Sebi regulations define "insider" as a company associate who is trading in the company's shares based on unpublished price sensitive information (UPSI) to make a quick buck

'Christie fiction': Biocon chief slams Sebi order on Allegro Capital

The case dates back to January 2018, when Biocon had announced an exclusive global collaboration with Sandoz on next-generation biosimilars

Covid has created an ecosystem of innovation in India: Kiran Mazumdar-Shaw

The ongoing Covid-19 public health crisis has resulted in the creation of an "ecosystem" of innovation in India, Biocon chief Kiran Mazumdar-Shaw has said

Second wave of Covid-19 has hit India 'like a tsunami': Kiran Mazumdar Shaw

The unprecedented spike in coronavirus cases to the recent state elections and religious festivals in the country, says Kiran Mazumdar Shaw

Covid second wave has hit India 'like a tsunami' says Kiran Mazumdar Shaw

Biocon founder Kiran Mazumdar Shaw attributed the unprecedented spike in coronavirus cases to the recent state elections and religious festivals in the country

Govt should have built safety stock of essential drugs: Kiran Mazumdar-Shaw

The Biocon founder and Executive Chairperson points out that drugs like Remdesivir should be allowed at home as an emergency step

Amid pandemic, auctioneers paint a profitable canvas with hybrid auctions

Digital sales increase turnover for auctioneers - for some, by 20 per cent

Companies 'feel betrayed' due to capping of Covid-19 vaccine price: Shaw

She further said, "Covid Vaccine Jab Capped At Rs 250 At Private Hospitals: Government - understand vaccine cos (sic) feel betrayed as price is too low to sustain"

Women's economic empowerment vital to tackle gender inequality: Biocon head

Economic empowerment of women is extremely important to bridge the gap of gender inequality,US-India Business Council Vice Chair and Biocon Executive Chair Kiran Mazumdar-Shaw said on Thursday. Speaking at a virtual event on 'Expanding the US-India Partnership: Promoting Gender Diversity at Work', she said gender inequality starts with the skewed distribution that women face when it comes to the distribution of assets or inheritance or workplace employment or representation in socio-political institutions. "Economic empowerment is what will bridge the gap of gender inequality. I think economic empowerment of the women is extremely important," Mazumdar-Shaw said. Even in the corporate world, there is a lot of tokenism in everything we do, she said. Of the top 100 BSE companies in India, 91 have only one woman director, which means it is just sort of ticking a box. Moreover, when they want to find a woman for the board, it is the same group of women they are looking at. The canvas ha

Market reacts negatively to Biocon's weaker results, exit of biologics' MD

Analysts have raised doubts over the $1 billion guidance for biosimilars by FY22 and Hamacher's exit due to "professional differences"

Biocon posts 19% dip in Q3 net profit as generics biz takes a hit

Biocon's consolidated revenue for Q3 of FY21 increased by 7.20 per cent at Rs 1878.9 crore as against Rs 1752.6 crore for the said quarter last year

Kamala Harris to Bilkis Dadi, here are the women who helped shape 2020

With just 8 days left for this year to end, let's take a look at these women who inspired millions with their outstanding contribution